{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:41:24Z","timestamp":1791841284166,"version":"4.3.4"},"reference-count":321,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,6,1]]},"DOI":"10.1210\/er.2002-0010","type":"journal-article","created":{"date-parts":[[2003,6,4]],"date-time":"2003-06-04T21:04:07Z","timestamp":1054760647000},"page":"278-301","source":"Crossref","is-referenced-by-count":670,"title":["Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome"],"prefix":"10.1210","volume":"24","author":[{"given":"Jose\u0301 Manuel","family":"Ferna\u0301ndez-Real","sequence":"first","affiliation":[{"name":"Section of Diabetes, Endocrinology and Nutrition, University Hospital of Girona \u201cDr. Josep Trueta,\u201d 17007 Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wifredo","family":"Ricart","sequence":"additional","affiliation":[{"name":"Section of Diabetes, Endocrinology and Nutrition, University Hospital of Girona \u201cDr. Josep Trueta,\u201d 17007 Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"2019041122173626900_R1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Role of insulin resistance in human disease.","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"2019041122173626900_R2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000022953","article-title":"Epidemiology and factor analysis of obesity, type II diabetes, hypertension, and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia.","volume":"51","author":"Shmulewitz","year":"2001","journal-title":"Hum Hered"},{"key":"2019041122173626900_R3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI10762","article-title":"Insulin resistance and cardiovascular disease.","volume":"106","author":"Ginsberg","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R4","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/01.CIR.93.10.1809","article-title":"Insulin sensitivity and atherosclerosis.","volume":"93","author":"Howard","year":"1996","journal-title":"Circulation"},{"key":"2019041122173626900_R5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis: an inflammatory disease?","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"2019041122173626900_R6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low grade inflammation and coronary heart disease: a prospective study and updated meta-analyses.","volume":"321","author":"Danesh","year":"2000","journal-title":"BMJ"},{"key":"2019041122173626900_R7","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s001250050822","article-title":"NIDDM as a disease of the innate immune system: association of the acute-phase reactants and interleukin 6 with metabolic syndrome X.","volume":"40","author":"Pickup","year":"1997","journal-title":"Diabetologia"},{"key":"2019041122173626900_R8","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s001250051058","article-title":"Is type II diabetes a disease of the innate immune system?","volume":"41","author":"Pickup","year":"1998","journal-title":"Diabetologia"},{"key":"2019041122173626900_R9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s001250051451","article-title":"Insulin resistance and inflammation in an evolutionary perspective. The contribution of cytokine genotype\/phenotype to thriftiness.","volume":"42","author":"Ferna\u0301ndez-Real","year":"1999","journal-title":"Diabetologia"},{"key":"2019041122173626900_R10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).","volume":"102","author":"Festa","year":"2000","journal-title":"Circulation"},{"key":"2019041122173626900_R11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0026-0495(98)90005-1","article-title":"Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance.","volume":"37","author":"Svenson","year":"1988","journal-title":"Metabolism"},{"key":"2019041122173626900_R12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/0026-0495(87)90128-4","article-title":"Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones.","volume":"36","author":"Svenson","year":"1987","journal-title":"Metabolism"},{"key":"2019041122173626900_R13","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/01.ATV.13.12.1865","article-title":"Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.","volume":"13","author":"Juhan-Vague","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"2019041122173626900_R14","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(99)01046-6","article-title":"Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study.","volume":"353","author":"Schmidt","year":"1999","journal-title":"Lancet"},{"key":"2019041122173626900_R15","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2337\/diabetes.50.7.1598","article-title":"Gamma globulin levels predict type 2 diabetes in the Pima Indian population.","volume":"50","author":"Lindsay","year":"2001","journal-title":"Diabetes"},{"key":"2019041122173626900_R16","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.2337\/diabetes.50.10.2384","article-title":"The relation of markers of inflammation to the development of glucose disorders in the elderly. The Cardiovascular Health Study.","volume":"50","author":"Barzilay","year":"2001","journal-title":"Diabetes"},{"key":"2019041122173626900_R17","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJM200106283442609","article-title":"Statins and the acute phase response.","volume":"344","author":"Munford","year":"2001","journal-title":"N Engl J Med"},{"key":"2019041122173626900_R18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0895-7061(01)02072-6","article-title":"Role of abnormal nitric oxide systems in salt-sensitive hypertension.","volume":"14","author":"Manning Jr","year":"2001","journal-title":"Am J Hypertens"},{"key":"2019041122173626900_R19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00041552-200203000-00009","article-title":"Nitric oxide synthase and hypertension.","volume":"11","author":"Leclercq","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2019041122173626900_R20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s004390100565","article-title":"Chromosome 17 and the inducible nitric oxide synthase gene in human essential hypertension.","volume":"109","author":"Rutherford","year":"2001","journal-title":"Hum Genet"},{"key":"2019041122173626900_R21","first-page":"E692","article-title":"Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent","volume":"274","author":"Roy","year":"1998","journal-title":"Am J Physiol"},{"key":"2019041122173626900_R22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nm1001-1138","article-title":"Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle.","volume":"7","author":"Perreault","year":"2001","journal-title":"Nat Med"},{"key":"2019041122173626900_R23","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1998.06806.x","article-title":"Angiotensin II, nitric oxide, and end-organ damage in hypertension","volume":"68","author":"Bataineh","year":"1998","journal-title":"Kidney Int Suppl"},{"key":"2019041122173626900_R24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11906-001-0082-y","article-title":"Angiotensin, inflammation, hypertension, and cardiovascular disease.","volume":"3","author":"Luft","year":"2001","journal-title":"Curr Hypertens Rep"},{"key":"2019041122173626900_R25","author":"Dzielak","year":"1992"},{"key":"2019041122173626900_R26","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/00004872-199511000-00007","article-title":"Do immune system changes have a role in hypertension?","volume":"13","author":"Fu","year":"1995","journal-title":"J Hypertens"},{"key":"2019041122173626900_R27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/bmj.2.5702.146","article-title":"Raised serum IgG levels in hypertension.","volume":"2","author":"Ebringer","year":"1970","journal-title":"Br Med J"},{"key":"2019041122173626900_R28","first-page":"775","article-title":"Raised levels of immunoglobulins in serum of hypertensive patients.","volume":"81","author":"Olsen","year":"1973","journal-title":"Acta Pathol Microbiol Scand"},{"key":"2019041122173626900_R29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.0954-6820.1978.tb14830.x","article-title":"Increased serum levels of immunoglobulins in untreated and treated essential hypertension.","volume":"203","author":"Kristensen","year":"1978","journal-title":"Acta Med Scand"},{"key":"2019041122173626900_R30","first-page":"196","article-title":"Delayed hypersensitivity and borderline essential hypertension.","volume":"85","author":"Olsen","year":"1977","journal-title":"Acta Pathol Microbiol Scand"},{"key":"2019041122173626900_R31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/cs061363s","article-title":"Association between the C3-F gene and essential hypertension.","volume":"61","author":"Schaadt","year":"1981","journal-title":"Clin Sci (Lond)"},{"key":"2019041122173626900_R32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/01.CIR.58.4.622","article-title":"Association between coronary heart disease and the C3-F gene in essential hypertension.","volume":"58","author":"Kristensen","year":"1978","journal-title":"Circulation"},{"key":"2019041122173626900_R33","first-page":"345","article-title":"Relationship between serum C3 levels and traditional risk factors for myocardial infarction.","volume":"53","author":"Muscari","year":"1998","journal-title":"Acta Cardiol"},{"key":"2019041122173626900_R34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1053\/euhj.1999.2013","article-title":"Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men.","volume":"21","author":"Muscari","year":"2000","journal-title":"Eur Heart J"},{"key":"2019041122173626900_R35","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2337\/diacare.23.6.779","article-title":"Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration.","volume":"23","author":"Weyer","year":"2000","journal-title":"Diabetes Care"},{"key":"2019041122173626900_R36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.HYP.15.1.89","article-title":"Antihypertensive effect of interleukin-2.","volume":"15","author":"Tutle","year":"1990","journal-title":"Hypertension"},{"key":"2019041122173626900_R37","first-page":"163","article-title":"Effect of cytokines on the production of endothelin by endothelial cells.","volume":"15","author":"Kahaleh","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"2019041122173626900_R38","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1161\/01.HYP.27.4.1009","article-title":"Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator.","volume":"27","author":"Brasier","year":"1996","journal-title":"Hypertension"},{"key":"2019041122173626900_R39","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/01.HYP.30.4.859","article-title":"Tissue angiotensinogen gene expression induced by lipopolysaccharide in hypertensive rats.","volume":"30","author":"Nyui","year":"1997","journal-title":"Hypertension"},{"key":"2019041122173626900_R40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.HYP.36.1.14","article-title":"Role of tumor necrosis factor-\u03b1 gene locus in obesity and obesity-associated hypertension in French Canadians.","volume":"36","author":"Pausova","year":"2000","journal-title":"Hypertension"},{"key":"2019041122173626900_R41","first-page":"272","article-title":"Circulating tumor necrosis factor-\u03b1 concentrations in a native Canadian population with high rates of type 2 diabetes mellitus.","volume":"84","author":"Zinman","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.HYP.34.1.113","article-title":"Preactivated peripheral blood monocytes in patients with essential hypertension.","volume":"34","author":"Do\u0308rffel","year":"1999","journal-title":"Hypertension"},{"key":"2019041122173626900_R43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1464-5491.1999.00052.x","article-title":"Elevated serum TNF-\u03b1 levels as a link between endothelial dysfunction and insulin resistance in normotensive obese subjects.","volume":"16","author":"Winkler","year":"1999","journal-title":"Diabet Med"},{"key":"2019041122173626900_R44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0167-5699(92)90116-O","article-title":"Two TNF receptors.","volume":"13","author":"Tartaglia","year":"1992","journal-title":"Immunol Today"},{"key":"2019041122173626900_R45","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0092-8674(94)90372-7","article-title":"The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death.","volume":"76","author":"Smith","year":"1994","journal-title":"Cell"},{"key":"2019041122173626900_R46","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1002\/j.1460-2075.1990.tb07526.x","article-title":"Soluble forms of tumor necrosis factors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor.","volume":"9","author":"Nophar","year":"1990","journal-title":"EMBO J"},{"key":"2019041122173626900_R47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1084\/jem.175.2.323","article-title":"Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.","volume":"175","author":"Aderka","year":"1992","journal-title":"J Exp Med"},{"key":"2019041122173626900_R48","first-page":"157","article-title":"Variation in serum levels of the soluble TNF receptors among healthy individuals.","volume":"11","author":"Aderka","year":"1992","journal-title":"Lymphokine Cytokine Res"},{"key":"2019041122173626900_R49","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1172\/JCI694","article-title":"Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.","volume":"101","author":"Aderka","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R50","doi-asserted-by":"crossref","first-page":"E952","DOI":"10.1152\/ajpendo.00444.2001","article-title":"Shedding of tumor necrosis factor-\u03b1 receptors, blood pressure and insulin sensitivity in type 2 diabetes mellitus","volume":"282","author":"Ferna\u0301ndez-Real","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041122173626900_R51","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1210\/jcem.86.3.7305","article-title":"Circulating interleukin 6 levels, blood pressure and insulin sensitivity in apparently healthy men and women.","volume":"86","author":"Ferna\u0301ndez-Real","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R52","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1210\/jcem.85.3.6355","article-title":"Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study.","volume":"85","author":"Straub","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R53","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.HYP.38.3.399","article-title":"Blood pressure and inflammation in apparently healthy men.","volume":"38","author":"Chae","year":"2001","journal-title":"Hypertension"},{"key":"2019041122173626900_R54","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1053\/euhj.2001.2678","article-title":"The interleukin-6\u2013174 G\/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.","volume":"22","author":"Humphries","year":"2001","journal-title":"Eur Heart J"},{"key":"2019041122173626900_R55","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.jhh.1001462","article-title":"The \u2212174 G\/C polymorphism of the interleukin-6 gene promoter and essential hypertension in an elderly Italian population.","volume":"16","author":"Pola","year":"2002","journal-title":"J Hum Hypertens"},{"key":"2019041122173626900_R56","first-page":"E601","article-title":"Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines","volume":"271","author":"Papanicolaou","year":"1996","journal-title":"Am J Physiol"},{"key":"2019041122173626900_R57","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1210\/edrv-17-1-64","article-title":"Immune-neuro-endocrine interactions.","volume":"17","author":"Besedovsky","year":"1996","journal-title":"Endocr Rev"},{"key":"2019041122173626900_R58","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/1529-0131(200004)43:4<872::AID-ANR19>3.0.CO;2-T","article-title":"Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.","volume":"43","author":"Torpy","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2019041122173626900_R59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/01.HYP.36.1.103","article-title":"Molecular plasticity of vascular wall during N(G)-nitro-l-arginine methyl ester-induced hypertension: modulation of proinflammatory signals.","volume":"36","author":"Gonzalez","year":"2000","journal-title":"Hypertension"},{"key":"2019041122173626900_R60","first-page":"83","article-title":"Induction of an acute phase response in rats stimulates the expression of \u03b1 1(I) procollagen messenger ribonucleic acid in their livers. Possible role of interleukin-6.","volume":"72","author":"Greenwel","year":"1995","journal-title":"Lab Invest"},{"key":"2019041122173626900_R61","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0268-9499(99)90084-X","article-title":"Coagulation, fibrinolysis and cardiovascular disease.","volume":"13","author":"Lowe","year":"1999","journal-title":"Fibrinolysis Proteolysis"},{"key":"2019041122173626900_R62","first-page":"201","article-title":"Interleukin 6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen.","volume":"45","author":"Takano","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"2019041122173626900_R63","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1189\/jlb.68.4.437","article-title":"Leptin in the regulation of immunity, inflammation, and hematopoiesis.","volume":"68","author":"Fantuzzi","year":"2000","journal-title":"J Leukoc Biol"},{"key":"2019041122173626900_R64","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI119532","article-title":"Receptor-mediated regional sympathetic nerve activation by leptin.","volume":"100","author":"Haynes","year":"1997","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/01.HYP.31.1.409","article-title":"Chronic leptin infusion increases arterial pressure.","volume":"31","author":"Shek","year":"1998","journal-title":"Hypertension"},{"key":"2019041122173626900_R66","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI8341","article-title":"Pathophysiological role of leptin in obesity-related hypertension.","volume":"105","author":"Aizawa-Abe","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R67","first-page":"3126","article-title":"Hypertension in obesity and the leptin receptor gene locus.","volume":"85","author":"Rosmond","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R68","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/01.HYP.33.1.271","article-title":"TGF-\u03b21 DNA polymorphisms, protein levels and blood pressure.","volume":"33","author":"Li","year":"1999","journal-title":"Hypertension"},{"issue":"Suppl 3","key":"2019041122173626900_R69","doi-asserted-by":"crossref","first-page":"S462","DOI":"10.1086\/315611","article-title":"Infection and inflammation-induced proatherogenic changes of lipoproteins","volume":"181","author":"Khovidhunkit","year":"2000","journal-title":"J Infect Dis"},{"key":"2019041122173626900_R70","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00041433-199405030-00008","article-title":"Effects of endotoxin and cytokines on lipid metabolism.","volume":"5","author":"Hardardottir","year":"1994","journal-title":"Curr Opin Lipidol"},{"key":"2019041122173626900_R71","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.iy.07.040189.003205","article-title":"The biology of cachectin\/TNF\u2014a primary mediator of the host response.","volume":"7","author":"Beutler","year":"1989","journal-title":"Annu Rev Immunol"},{"issue":"Suppl 2","key":"2019041122173626900_R72","first-page":"97","article-title":"Role of cytokines in inducing hyperlipidemia","volume":"41","author":"Grunfeld","year":"1992","journal-title":"Diabetes"},{"key":"2019041122173626900_R73","first-page":"1045","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.","volume":"74","author":"Grunfeld","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R74","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1203\/00006450-199308000-00011","article-title":"Circulating tumor necrosis factor-\u03b1 levels and lipid abnormalities in patients with cystic fibrosis.","volume":"34","author":"Levy","year":"1993","journal-title":"Pediatr Res"},{"key":"2019041122173626900_R75","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0009-8981(98)00050-3","article-title":"Lipoprotein alterations in patients with HIV infection: relation with cellular and humoral immune markers.","volume":"274","author":"Fernandez-Miranda","year":"1998","journal-title":"Clin Chim Acta"},{"key":"2019041122173626900_R76","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0021-9150(99)00156-2","article-title":"Plasma levels of the soluble fraction of tumor necrosis factor-\u03b1 receptors 1 and 2 are independent determinants of total and LDL-cholesterol concentrations in healthy subjects.","volume":"146","author":"Ferna\u0301ndez-Real","year":"1999","journal-title":"Atherosclerosis"},{"key":"2019041122173626900_R77","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2337\/diab.46.3.451","article-title":"Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance.","volume":"46","author":"Hotamisligil","year":"1997","journal-title":"Diabetes"},{"key":"2019041122173626900_R78","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2337\/diabetes.47.11.1757","article-title":"Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.","volume":"47","author":"Ferna\u0301ndez-Real","year":"1998","journal-title":"Diabetes"},{"key":"2019041122173626900_R79","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/euhj.2001.2805","article-title":"Plasma tumour necrosis factor-\u03b1 and early carotid atherosclerosis in healthy middle-aged men.","volume":"23","author":"Skoog","year":"2002","journal-title":"Eur Heart J"},{"key":"2019041122173626900_R80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0026-0495(98)90203-7","article-title":"Evidence for a role of tumor necrosis factor \u03b1 in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease.","volume":"47","author":"Jovinge","year":"1998","journal-title":"Metabolism"},{"key":"2019041122173626900_R81","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0022-2275(20)42750-6","article-title":"Lipopolysaccharide and tumor necrosis factor cause a fall in plasma concentration of lecithin: cholesterol acyltransferase in cynomolgus monkeys.","volume":"31","author":"Ettinger","year":"1990","journal-title":"J Lipid Res"},{"key":"2019041122173626900_R82","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1210\/endo.132.5.8477669","article-title":"Tumor necrosis factor mediates the effect of endotoxin on cholesterol and triglyceride metabolism in mice.","volume":"132","author":"Memon","year":"1993","journal-title":"Endocrinology"},{"key":"2019041122173626900_R83","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1074\/jbc.273.9.5053","article-title":"Tumor necrosis factor-\u03b1 stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase.","volume":"273","author":"Lawler Jr","year":"1998","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"2019041122173626900_R84","first-page":"S24","article-title":"Regulation of lipid metabolism by cytokines during host defense","volume":"12","author":"Grunfeld","year":"1996","journal-title":"Nutrition"},{"issue":"Suppl 3","key":"2019041122173626900_R85","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.2337\/diab.45.3.S40","article-title":"Cytokines, modified lipoproteins, and arteriosclerosis in diabetes","volume":"45","author":"Lopes-Virella","year":"1996","journal-title":"Diabetes"},{"key":"2019041122173626900_R86","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0735-1097(98)00093-X","article-title":"Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease.","volume":"31","author":"Mehta","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2019041122173626900_R87","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2249.1995.tb08364.x","article-title":"Increase lipopolysaccharide-induced tumour necrosis factor levels and death in hypercholesterolaemic rabbits.","volume":"101","author":"Brito","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"2019041122173626900_R88","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/01.RES.81.2.274","article-title":"Low-density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli.","volume":"81","author":"Henninger","year":"1997","journal-title":"Circ Res"},{"key":"2019041122173626900_R89","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/jn\/122.2.294","article-title":"Atherogenic diets enhance endotoxin-stimulated interleukin-1 and tumor necrosis factor gene expression in rabbit aortae.","volume":"122","author":"Fleet","year":"1992","journal-title":"J Nutr"},{"key":"2019041122173626900_R90","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s001090000168","article-title":"Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease.","volume":"79","author":"Benjafield","year":"2001","journal-title":"J Mol Med"},{"key":"2019041122173626900_R91","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/01.CIR.96.5.1381","article-title":"Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia.","volume":"96","author":"Sampietro","year":"1997","journal-title":"Circulation"},{"key":"2019041122173626900_R92","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0033-0620(98)80008-X","article-title":"Cholesterol, cholesterol lowering, and endothelial function.","volume":"41","author":"Vogel","year":"1998","journal-title":"Prog Cardiovasc Dis"},{"key":"2019041122173626900_R93","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI109587","article-title":"Low density lipoprotein receptor activity in cultured human skin fibroblasts: mechanism of insulin-induced stimulation.","volume":"64","author":"Chait","year":"1979","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R94","first-page":"4113","article-title":"Interleukin-6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin-6 in cancer cachexia.","volume":"52","author":"Greenberg","year":"1992","journal-title":"Cancer Res"},{"key":"2019041122173626900_R95","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1210\/endo.136.5.7720663","article-title":"Interleukin-6 stimulates hepatic triglyceride secretion in rats.","volume":"136","author":"Nonogaki","year":"1995","journal-title":"Endocrinology"},{"key":"2019041122173626900_R96","first-page":"E813","article-title":"Endocrinologic and metabolic effects of interleukin-6 in humans","volume":"268","author":"Stouthard","year":"1995","journal-title":"Am J Physiol"},{"key":"2019041122173626900_R97","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1210\/jcem.85.3.6555","article-title":"Interleukin 6 gene polymorphism and lipid abnormalities in healthy subjects.","volume":"85","author":"Ferna\u0301ndez-Real","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R98","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3181\/00379727-200-43415","article-title":"Modulation of cytokine production by dietary polyunsaturated fatty acids.","volume":"200","author":"Meydani","year":"1992","journal-title":"Proc Soc Exp Biol Med"},{"key":"2019041122173626900_R99","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jn\/121.4.547","article-title":"Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women.","volume":"121","author":"Meydani","year":"1991","journal-title":"J Nutr"},{"key":"2019041122173626900_R100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198902023200501","article-title":"The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.","volume":"320","author":"Endres","year":"1989","journal-title":"N Engl J Med"},{"key":"2019041122173626900_R101","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ajcn\/71.1.213S","article-title":"Fatty acid modulation of endothelial activation.","volume":"71","author":"De Caterina","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"2019041122173626900_R102","first-page":"589","article-title":"Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6","volume":"400B","author":"Khalfoun","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"2019041122173626900_R103","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0022-2275(20)30151-6","article-title":"Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia.","volume":"43","author":"Han","year":"2002","journal-title":"J Lipid Res"},{"key":"2019041122173626900_R104","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2337\/diacare.26.5.1362","article-title":"Insulin resistance, inflammation and serum fatty acid composition.","volume":"26","author":"Ferna\u0301ndez-Real","year":"2003","journal-title":"Diabetes Care"},{"key":"2019041122173626900_R105","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1053\/meta.2001.28084","article-title":"Circulating granulocyte-macrophage colony stimulating factor and serum fatty acid composition in men and women.","volume":"50","author":"Ferna\u0301ndez-Real","year":"2001","journal-title":"Metabolism"},{"key":"2019041122173626900_R106","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2169\/internalmedicine.38.202","article-title":"Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity.","volume":"38","author":"Funahashi","year":"1999","journal-title":"Intern Med"},{"key":"2019041122173626900_R107","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-\u03b1: direct role in obesity-linked insulin resistance.","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"2019041122173626900_R108","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1172\/JCI117495","article-title":"Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes.","volume":"94","author":"Hotamisligil","year":"1994","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R109","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-\u03b1- and obesity-induced insulin resistance.","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"2019041122173626900_R110","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2337\/diab.43.11.1271","article-title":"Tumor necrosis factor \u03b1: a key component of the obesity-diabetes link.","volume":"43","author":"Hotamisligil","year":"1994","journal-title":"Diabetes"},{"key":"2019041122173626900_R111","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI117899","article-title":"The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.","volume":"95","author":"Kern","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R112","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-\u03b1 in human obesity and insulin resistance.","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R113","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI118504","article-title":"The expression of TNF\u03b1 by human muscle. Relationship to insulin resistance.","volume":"97","author":"Saghizadeh","year":"1996","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R114","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2337\/diabetes.51.6.1876","article-title":"Altered tumor necrosis factor-\u03b1 (TNF-\u03b1) processing in adipocytes and increased expression of transmembrane TNF-\u03b1 in obesity.","volume":"51","author":"Xu","year":"2002","journal-title":"Diabetes"},{"key":"2019041122173626900_R115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-2275(20)42065-6","article-title":"Expression of lipoprotein lipase in different human subcutaneous adipose tissue regions.","volume":"32","author":"Arner","year":"1991","journal-title":"J Lipid Res"},{"key":"2019041122173626900_R116","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.ijo.0800773","article-title":"Plasma concentrations of soluble TNF-\u03b1 receptors in obese subjects.","volume":"22","author":"Hauner","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041122173626900_R117","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.ijo.0800826","article-title":"Relationship between plasma leptin levels and the tumor necrosis factor-\u03b1 system in obese subjects.","volume":"23","author":"Corica","year":"1999","journal-title":"Int J Obes Rel Metab Dis"},{"key":"2019041122173626900_R118","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/eje.0.1460325","article-title":"Plasma soluble tumor necrosis factor \u03b1 receptors and leptin levels in normal-weight and obese women: effect of adiposity and diabetes.","volume":"146","author":"Bullo","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"2019041122173626900_R119","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0021-9150(00)00755-3","article-title":"Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men.","volume":"157","author":"Chu","year":"2001","journal-title":"Atherosclerosis"},{"key":"2019041122173626900_R120","first-page":"2728","article-title":"Serum soluble tumor necrosis factor-\u03b1 receptor 2 is elevated in obesity but is not related to insulin sensitivity: a study in identical twins discordant for obesity.","volume":"85","author":"Ro\u0308nnemaa","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R121","first-page":"E971","article-title":"Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo","volume":"277","author":"Mohamed-Ali","year":"1999","journal-title":"Am J Physiol"},{"key":"2019041122173626900_R122","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1463-1326.2000.00090.x","article-title":"Variations in plasma soluble tumour necrosis factor receptors after diet-induced weight loss in obesity.","volume":"2","author":"Bastard","year":"2000","journal-title":"Diabetes Obes Metab"},{"key":"2019041122173626900_R123","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1084\/jem.185.1.171","article-title":"Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia.","volume":"185","author":"Sarraf","year":"1997","journal-title":"J Exp Med"},{"key":"2019041122173626900_R124","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI118653","article-title":"Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. A role for leptin in the anorexia of infection.","volume":"97","author":"Grunfeld","year":"1996","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R125","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1172\/JCI119824","article-title":"Tumor necrosis factor-\u03b1 contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes.","volume":"100","author":"Kirchgessner","year":"1997","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R126","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1006\/bbrc.1998.8680","article-title":"Leptin regulation of peroxisome proliferator-activated receptor-\u03b3, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissues.","volume":"246","author":"Qian","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122173626900_R127","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1210\/jcem.82.12.4408","article-title":"Tumor necrosis factor increases serum leptin levels in humans.","volume":"82","author":"Zumbach","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R128","first-page":"3408","article-title":"Leptin concentrations in relation to body mass index and the tumor necrosis factor-\u03b1 system in humans.","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R129","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diab.44.7.855","article-title":"Human obese gene expression. Adipocyte specific expression and regional differences in the adipose tissue.","volume":"44","author":"Masuzaki","year":"1995","journal-title":"Diabetes"},{"key":"2019041122173626900_R130","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.1073\/pnas.93.25.14564","article-title":"Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells.","volume":"93","author":"Gainsford","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122173626900_R131","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.ijo.0801825","article-title":"Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals.","volume":"25","author":"van Dielen","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041122173626900_R132","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.ijo.0801952","article-title":"The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects.","volume":"26","author":"Hukshorn","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041122173626900_R133","first-page":"847","article-title":"Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid.","volume":"83","author":"Fried","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R134","first-page":"2126","article-title":"The differential effect of food intake and \u03b2-adrenergic stimulation on adipose-derived hormones and cytokines in man.","volume":"84","author":"Orban","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R135","first-page":"4196","article-title":"Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-\u03b1, in vivo.","volume":"82","author":"Mohamed-Ali","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R136","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1210\/jcem.82.5.3950","article-title":"Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity.","volume":"82","author":"Vgontzas","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R137","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1172\/JCI117100","article-title":"17\u03b2-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism.","volume":"93","author":"Pottratz","year":"1994","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R138","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s100380300002","article-title":"The interleukin 6 \u2212174G\/C polymorphism is associated with indices of obesity in men.","volume":"48","author":"Berthier","year":"2003","journal-title":"J Hum Genet"},{"key":"2019041122173626900_R139","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm0102-75","article-title":"Interleukin-6-deficient mice develop mature-onset obesity.","volume":"8","author":"Wallenius","year":"2002","journal-title":"Nat Med"},{"key":"2019041122173626900_R140","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nm724","article-title":"Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30.","volume":"8","author":"Maeda","year":"2002","journal-title":"Nat Med"},{"key":"2019041122173626900_R141","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.ijo.0801373","article-title":"Moderate-intensity regular exercise decreases serum tumor necrosis factor-\u03b1 and HbA1c levels in healthy women.","volume":"24","author":"Tsukui","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041122173626900_R142","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2337\/diacare.26.3.875","article-title":"Soluble TNF\u03b1 receptors in young obese subjects with normal and impaired glucose tolerance.","volume":"26","author":"Dzienis-Straczkowska","year":"2003","journal-title":"Diabetes Care"},{"key":"2019041122173626900_R143","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/diabetes.48.5.1108","article-title":"The TNF system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.","volume":"48","author":"Ferna\u0301ndez-Real","year":"1999","journal-title":"Diabetes"},{"key":"2019041122173626900_R144","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.4049\/jimmunol.150.10.4346","article-title":"Selective up-regulation of the 75-kDa tumor necrosis (TNF) receptor and its mRNA by TNF and IL-1.","volume":"150","author":"Winzen","year":"1993","journal-title":"J Immunol"},{"key":"2019041122173626900_R145","first-page":"353","article-title":"Diabetes mellitus: a \u201cthrifty\u201d genotype rendered detrimental by \u201cprogress.\u201d","volume":"14","author":"Neel","year":"1962","journal-title":"Am J Hum Genet"},{"key":"2019041122173626900_R146","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s001250050933","article-title":"Hypothesis: muscle insulin resistance is the (\u201cnot-so\u201d) thrifty genotype.","volume":"41","author":"Reaven","year":"1998","journal-title":"Diabetologia"},{"key":"2019041122173626900_R147","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1056\/NEJM198501313120505","article-title":"Paleolithic nutrition. A consideration of its nature and current implications.","volume":"312","author":"Eaton","year":"1985","journal-title":"N Engl J Med"},{"key":"2019041122173626900_R148","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0002-9343(88)90113-1","article-title":"Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective.","volume":"84","author":"Eaton","year":"1988","journal-title":"Am J Med"},{"key":"2019041122173626900_R149","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2337\/diab.40.2.161","article-title":"Archaeology of NIDDM. Excavation of the \u201cthrifty\u201d genotype.","volume":"40","author":"Wendorf","year":"1991","journal-title":"Diabetes"},{"key":"2019041122173626900_R150","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0167-5699(98)01255-9","article-title":"Exercise immunology: integration and regulation.","volume":"19","author":"Pedersen","year":"1998","journal-title":"Immunol Today"},{"key":"2019041122173626900_R151","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00005768-199805000-00005","article-title":"Influence of mode and carbohydrate on the cytokine response to heavy exertion.","volume":"30","author":"Nieman","year":"1998","journal-title":"Med Sci Sports Exerc"},{"key":"2019041122173626900_R152","first-page":"E336","article-title":"Postmarathon paradox: insulin resistance in the face of glycogen depletion","volume":"270","author":"Tuominen","year":"1996","journal-title":"Am J Physiol"},{"key":"2019041122173626900_R153","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/eje.0.1450273","article-title":"Changes in tumor necrosis factor-\u03b1 system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance.","volume":"145","author":"Straczkowski","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"2019041122173626900_R154","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1469-7793.2001.0329c.xd","article-title":"Muscle-derived interleukin-6: possible biological effects.","volume":"536","author":"Pedersen","year":"2001","journal-title":"J Physiol"},{"key":"2019041122173626900_R155","first-page":"P59","article-title":"Exercise induces interleukin-6 and interleukin 1\u03b2 expression within human skeletal muscle","volume":"531","author":"Schjerling","year":"2001","journal-title":"J Physiol"},{"key":"2019041122173626900_R156","doi-asserted-by":"crossref","first-page":"E196","DOI":"10.1152\/ajpendo.2000.279.1.E196","article-title":"Cytokines and endotoxin induce cytokine receptors in skeletal muscle","volume":"279","author":"Zhang","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041122173626900_R157","doi-asserted-by":"crossref","first-page":"42077","DOI":"10.1074\/jbc.M107101200","article-title":"Hyperglycemia-induced production of acute phase reactants in adipose tissue.","volume":"276","author":"Lin","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041122173626900_R158","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0167-5699(94)90137-6","article-title":"The acute phase response.","volume":"15","author":"Baumann","year":"1994","journal-title":"Immunol Today"},{"key":"2019041122173626900_R159","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1749-6632.1995.tb32318.x","article-title":"Do posttranscriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1?","volume":"762","author":"Kushner","year":"1995","journal-title":"Ann NY Acad Sci"},{"key":"2019041122173626900_R160","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation.","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"2019041122173626900_R161","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/diabetes.49.3.517","article-title":"Interleukin 6 and insulin sensitivity.","volume":"49","author":"Ferna\u0301ndez-Real","year":"2000","journal-title":"Diabetes"},{"key":"2019041122173626900_R162","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/MCB.12.4.1789","article-title":"Insulin is a prominent modulator of the cytokine-stimulated expression of acute-plasma protein genes.","volume":"12","author":"Campos","year":"1992","journal-title":"Mol Cell Biol"},{"key":"2019041122173626900_R163","first-page":"E323","article-title":"Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes","volume":"269","author":"O\u2019Riordain","year":"1995","journal-title":"Am J Physiol"},{"key":"2019041122173626900_R164","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0026-0495(89)90038-3","article-title":"Increased levels of acute-phase proteins in diabetes.","volume":"38","author":"McMillan","year":"1989","journal-title":"Metabolism"},{"key":"2019041122173626900_R165","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults.","volume":"282","author":"Visser","year":"1999","journal-title":"JAMA"},{"key":"2019041122173626900_R166","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2337\/diacare.22.12.1971","article-title":"Body mass index, diabetes, and C-reactive protein among U.S. adults.","volume":"22","author":"Ford","year":"1999","journal-title":"Diabetes Care"},{"key":"2019041122173626900_R167","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/diabetes.51.4.1131","article-title":"Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes. The Insulin Resistance Atherosclerosis Study.","volume":"51","author":"Festa","year":"2002","journal-title":"Diabetes"},{"key":"2019041122173626900_R168","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0021-9150(02)00371-4","article-title":"Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes.","volume":"166","author":"Leinonen","year":"2003","journal-title":"Atherosclerosis"},{"key":"2019041122173626900_R169","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ijo.0802017","article-title":"The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the metabolic syndrome\u2014an analysis by structural equation modelling.","volume":"26","author":"Chan","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041122173626900_R170","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.ijo.0801970","article-title":"Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention.","volume":"26","author":"Laimer","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041122173626900_R171","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00075197-200209000-00015","article-title":"Inflammatory status and insulin resistance.","volume":"5","author":"Grimble","year":"2002","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2019041122173626900_R172","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1177\/153537020222701106","article-title":"Is metabolic syndrome X an inflammatory condition?","volume":"227","author":"Das","year":"2002","journal-title":"Exp Biol Med"},{"key":"2019041122173626900_R173","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1055\/s-2007-978662","article-title":"Enhanced acute-phase response and oxidative stress in older adults with type II diabetes.","volume":"32","author":"Arnalich","year":"2000","journal-title":"Horm Metab Res"},{"key":"2019041122173626900_R174","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.4049\/jimmunol.160.11.5294","article-title":"Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice.","volume":"160","author":"Szalai","year":"1998","journal-title":"J Immunol"},{"key":"2019041122173626900_R175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/edrv-11-1-80","article-title":"The functions of corticosteroid binding globulin and sex-hormone binding globulin: recent advances.","volume":"11","author":"Rosner","year":"1990","journal-title":"Endocr Rev"},{"key":"2019041122173626900_R176","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/1043-2760(95)00162-X","article-title":"Potential functions of plasma steroid-binding proteins.","volume":"6","author":"Hammond","year":"1995","journal-title":"Trends Endocrinol Metab"},{"key":"2019041122173626900_R177","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1210\/jcem.84.9.5946","article-title":"Plasma total and glycosylated corticosteroid-binding globulin levels are associated with insulin secretion.","volume":"84","author":"Ferna\u0301ndez-Real","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R178","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1053\/meta.2001.25647","article-title":"Study of the effect of changing glucose, insulin, and insulin-like growth factor-I levels on serum corticosteroid binding globulin in lean, obese, and obese subjects with glucose intolerance.","volume":"50","author":"Ferna\u0301ndez-Real","year":"2001","journal-title":"Metabolism"},{"key":"2019041122173626900_R179","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1210\/jc.2001-011843","article-title":"Serum corticosteroid binding globulin (CBG) and the insulin resistance syndrome: a population study.","volume":"87","author":"Ferna\u0301ndez-Real","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R180","first-page":"1283","article-title":"Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells.","volume":"80","author":"Crave","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R181","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1210\/endo.133.1.8391424","article-title":"Interleukin-6 inhibits cortisosteroid-binding globulin synthesis by human hepatoblastoma-derived (HepG2) cells.","volume":"133","author":"Bartalena","year":"1993","journal-title":"Endocrinology"},{"key":"2019041122173626900_R182","first-page":"3758","article-title":"Corticosteroid-binding globulin synthesis regulation by cytokines and glucocorticoids in human hepatoblastoma-derived (HepG2) cells.","volume":"82","author":"Emptoz-Bonneton","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R183","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/diab.42.7.995","article-title":"Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans.","volume":"42","author":"De Feo","year":"1993","journal-title":"Diabetes"},{"key":"2019041122173626900_R184","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00402539","article-title":"Dual effect of insulin on plasma volume and transcapillary albumin transport.","volume":"35","author":"Hilsted","year":"1992","journal-title":"Diabetologia"},{"key":"2019041122173626900_R185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/clinchem\/32.1.146","article-title":"Concentration of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women.","volume":"32","author":"Lapidus","year":"1986","journal-title":"Clin Chem"},{"key":"2019041122173626900_R186","first-page":"E294","article-title":"Advancing age and insulin resistance: role of plasma tumor necrosis factor-\u03b1","volume":"275","author":"Paolisso","year":"1998","journal-title":"Am J Physiol"},{"key":"2019041122173626900_R187","first-page":"906","article-title":"Effect of age on tests of the acute-phase response.","volume":"117","author":"Caswell","year":"1993","journal-title":"Arch Pathol Lab Med"},{"key":"2019041122173626900_R188","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/eji.1830230950","article-title":"Increased cytokine production in mononuclear cells of healthy elderly people.","volume":"23","author":"Fagiolo","year":"1993","journal-title":"Eur J Immunol"},{"key":"2019041122173626900_R189","first-page":"1714","article-title":"Plasma tumor necrosis factor-\u03b1 receptor 2 levels are associated with age.","volume":"23","author":"Ferna\u0301ndez-Real","year":"2000","journal-title":"Diabetes Care"},{"key":"2019041122173626900_R190","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2337\/diab.46.9.1526","article-title":"Targeted disruption of the tumor necrosis factor-\u03b1 gene. Metabolic consequences in obese and nonobese mice.","volume":"46","author":"Ventre","year":"1997","journal-title":"Diabetes"},{"key":"2019041122173626900_R191","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/39335","article-title":"Protection from obesity-induced insulin resistance in mice lacking TNF-\u03b1 function.","volume":"389","author":"Uysal","year":"1997","journal-title":"Nature"},{"key":"2019041122173626900_R192","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1073\/pnas.94.7.3195","article-title":"Effects of a polymorphism in the human tumour necrosis factor \u03b1 promoter on transcriptional activation.","volume":"94","author":"Wilson","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122173626900_R193","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s001250051673","article-title":"Tumour necrosis factor-\u03b1 (TNF-\u03b1) polymorphisms \u2212857C\/A and \u2212863C\/A are associated with TNF-\u03b1 secretion from human adipose tissue.","volume":"44","author":"Skoog","year":"2001","journal-title":"Diabetologia"},{"key":"2019041122173626900_R194","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2337\/diab.46.9.1468","article-title":"The TNF-\u03b1 Nco I polymorphism influences the relationship among insulin resistance, percent body fat and increased serum leptin levels.","volume":"46","author":"Ferna\u0301ndez-Real","year":"1997","journal-title":"Diabetes"},{"key":"2019041122173626900_R195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2362.1998.00244.x","article-title":"Polymorphisms of the tumour necrosis factor-\u03b1 gene, coronary heart disease and obesity.","volume":"28","author":"Herrmann","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"2019041122173626900_R196","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.ijo.0801576","article-title":"Tumor necrosis factor \u03b1 \u2212308 G\/A polymorphism in obese Caucasians.","volume":"25","author":"Brand","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041122173626900_R197","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s001250050015","article-title":"Excessive fat accumulation is associated with the TNF \u03b1-308 G\/A promoter polymorphism in women but not in men.","volume":"43","author":"Hoffstedt","year":"2000","journal-title":"Diabetologia"},{"key":"2019041122173626900_R198","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/oby.2002.55","article-title":"Association of the TNF-\u03b1 \u2212308 G\/A promoter polymorphism with insulin resistance in obesity.","volume":"10","author":"Dalziel","year":"2002","journal-title":"Obes Res"},{"key":"2019041122173626900_R199","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/gast.2002.31065","article-title":"Tumor necrosis factor \u03b1 promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease.","volume":"122","author":"Valenti","year":"2002","journal-title":"Gastroenterology"},{"key":"2019041122173626900_R200","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1053\/meta.2000.18560","article-title":"Tumor necrosis factor \u03b1 gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men.","volume":"49","author":"Ishii","year":"2000","journal-title":"Metabolism"},{"key":"2019041122173626900_R201","first-page":"149","article-title":"Tumour necrosis factor-\u03b1 (TNF-\u03b1) \u2212863C\/A polymorphism is associated with insulin sensitivity.","volume":"45","author":"Ferna\u0301ndez-Real","year":"2002","journal-title":"Diabetologia"},{"key":"2019041122173626900_R202","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1034\/j.1399-0039.2000.550508.x","article-title":"Susceptible locus for obese type 2 diabetes mellitus in the 5\u2032-flanking region of the tumor necrosis factor-\u03b1 gene.","volume":"55","author":"Kamizono","year":"2000","journal-title":"Tissue Antigens"},{"key":"2019041122173626900_R203","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1006\/bbrc.1995.1887","article-title":"Genetic variability in the TNF-\u03b1 promoter is not associated with type II diabetes mellitus (NIDDM).","volume":"211","author":"Hamann","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122173626900_R204","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.2337\/diabetes.48.10.2096","article-title":"Tumor necrosis factor-\u03b1 \u2212238 and \u2212308 polymorphisms do not associate with traits related to obesity and insulin resistance.","volume":"48","author":"Walston","year":"1999","journal-title":"Diabetes"},{"key":"2019041122173626900_R205","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s001250050926","article-title":"Tumour necrosis factor-\u03b1 gene promoter polymorphism and decreased insulin resistance.","volume":"41","author":"Day","year":"1998","journal-title":"Diabetologia"},{"key":"2019041122173626900_R206","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s001250050027","article-title":"The tumour necrosis factor \u03b1 \u2212238 G\/A and 308 G\/A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young relatives of type II diabetic patients.","volume":"43","author":"Koch","year":"2000","journal-title":"Diabetologia"},{"key":"2019041122173626900_R207","first-page":"1731","article-title":"The \u2212238 and \u2212308 G\/A polymorphisms of the tumor necrosis factor \u03b1 gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians.","volume":"85","author":"Rasmussen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R208","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/meta.2000.7704","article-title":"Tumor necrosis factor \u03b1 gene G-308A polymorphism in the metabolic syndrome.","volume":"49","author":"Lee","year":"2000","journal-title":"Metabolism"},{"key":"2019041122173626900_R209","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1053\/meta.2000.17710","article-title":"Tumor necrosis factor-\u03b2 gene NcoI polymorphism decreases insulin resistance in Japanese men.","volume":"49","author":"Hayakawa","year":"2000","journal-title":"Metabolism"},{"key":"2019041122173626900_R210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8227(01)00358-8","article-title":"Relationship of the tumor necrosis factor-\u03b1 \u2212308 A\/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus.","volume":"56","author":"Furuta","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"2019041122173626900_R211","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1172\/JCI2849","article-title":"Obesity and diabetes in TNF-\u03b1 receptor-deficient mice.","volume":"102","author":"Schreyer","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R212","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2337\/diacare.23.6.831","article-title":"A polymorphism of the tumor necrosis factor receptor-2 gene is associated with obesity, leptin levels and insulin resistance in young subjects and diet-treated type 2 diabetic patients.","volume":"23","author":"Ferna\u0301ndez-Real","year":"2000","journal-title":"Diabetes Care"},{"key":"2019041122173626900_R213","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/hmg\/9.13.1943","article-title":"Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor.","volume":"9","author":"Glenn","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2019041122173626900_R214","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/hmg\/9.14.2067","article-title":"Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.","volume":"9","author":"Geurts","year":"2000","journal-title":"Hum Mol Genet"},{"key":"2019041122173626900_R215","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1359\/jbmr.2000.15.7.1376","article-title":"Association of a polymorphism in the TNFR2 gene with low bone mineral density.","volume":"15","author":"Spotila","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2019041122173626900_R216","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1210\/jcem.87.8.8715","article-title":"The methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism.","volume":"87","author":"Peral","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R217","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1006\/bbrc.1997.7057","article-title":"The TNF-\u03b2 gene Nco I polymorphism is not associated with hypertriglyceridemia or insulin resistance in lean and obese subjects.","volume":"236","author":"Ferna\u0301ndez-Real","year":"1997","journal-title":"Biochem Biophys Res Comm"},{"key":"2019041122173626900_R218","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1365-2362.1998.00334.x","article-title":"Tumour necrosis factor \u03b2 alleles and hyperinsulinaemia in coronary artery disease.","volume":"28","author":"Braun","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"2019041122173626900_R219","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diab.45.7.881","article-title":"Effect of an engineered human anti-TNF-\u03b1 antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.","volume":"45","author":"Ofei","year":"1996","journal-title":"Diabetes"},{"key":"2019041122173626900_R220","first-page":"1316","article-title":"No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients.","volume":"85","author":"Paquot","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R221","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2337\/diacare.25.10.1824","article-title":"Increased plasma-soluble tumor necrosis factor-\u03b1 receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects.","volume":"25","author":"Straczkowski","year":"2002","journal-title":"Diabetes Care"},{"key":"2019041122173626900_R222","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00125-002-0829-2","article-title":"Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF\u03b1 or its receptors.","volume":"45","author":"Muller","year":"2002","journal-title":"Diabetologia"},{"key":"2019041122173626900_R223","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00439-003-0912-x","article-title":"The interleukin-6 (\u2212174) G\/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians.","volume":"112","author":"Vozarova","year":"2003","journal-title":"Hum Genet"},{"key":"2019041122173626900_R224","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2337\/diabetes.52.2.558","article-title":"The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity.","volume":"52","author":"Kubaszek","year":"2003","journal-title":"Diabetes"},{"key":"2019041122173626900_R225","doi-asserted-by":"crossref","first-page":"18138","DOI":"10.1074\/jbc.M000379200","article-title":"Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation.","volume":"275","author":"Terry","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041122173626900_R226","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1210\/jcem.85.3.6582","article-title":"Interleukin-6: the endocrine cytokine.","volume":"85","author":"Papanicolau","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R227","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2337\/diab.45.7.954","article-title":"Glucose-dependent interleukin-6 and tumor necrosis factor production by human peripheral blood monocytes in vitro.","volume":"45","author":"Morohoshi","year":"1996","journal-title":"Diabetes"},{"key":"2019041122173626900_R228","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/bj2720243","article-title":"Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6.","volume":"272","author":"Southern","year":"1990","journal-title":"Biochem J"},{"key":"2019041122173626900_R229","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1210\/endo-126-2-1288","article-title":"Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.","volume":"126","author":"Sandler","year":"1990","journal-title":"Endocrinology"},{"key":"2019041122173626900_R230","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1210\/jcem.82.12.4422","article-title":"Dose-dependent effects of recombinant human interleukin-6 on glucose regulation.","volume":"82","author":"Tsigos","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R231","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1046\/j.1365-2168.1998.00938.x","article-title":"Circulating interleukin 6 concentrations and insulin resistance in patients with cancer.","volume":"85","author":"Makin","year":"1998","journal-title":"Br J Surg"},{"key":"2019041122173626900_R232","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/oby.2001.54","article-title":"Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion.","volume":"9","author":"Vozarova","year":"2001","journal-title":"Obes Res"},{"key":"2019041122173626900_R233","doi-asserted-by":"crossref","first-page":"E745","DOI":"10.1152\/ajpendo.2001.280.5.E745","article-title":"Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance","volume":"280","author":"Kern","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041122173626900_R234","first-page":"3338","article-title":"Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.","volume":"85","author":"Bastard","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R235","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1210\/jcem.87.5.8450","article-title":"Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro.","volume":"87","author":"Bastard","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R236","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.2337\/diabetes.51.12.3391","article-title":"Interleukin-6 induces cellular insulin resistance in hepatocytes.","volume":"51","author":"Senn","year":"2002","journal-title":"Diabetes"},{"key":"2019041122173626900_R237","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"2019041122173626900_R238","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1210\/jcem-69-2-317","article-title":"Severity, duration, and mechanisms of insulin resistance during acute infections.","volume":"69","author":"Yki-Ja\u0308rvinen","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R239","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2796.1992.tb00582.x","article-title":"Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women.","volume":"232","author":"Facchini","year":"1992","journal-title":"J Intern Med"},{"key":"2019041122173626900_R240","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1365-2796.1996.815000.x","article-title":"The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals.","volume":"239","author":"Targher","year":"1996","journal-title":"J Intern Med"},{"key":"2019041122173626900_R241","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.1411569","article-title":"Interleukin-6 and its receptor: a paradigm for cytokines.","volume":"258","author":"Kishimoto","year":"1992","journal-title":"Science"},{"key":"2019041122173626900_R242","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2350-2-6","article-title":"Platelet count and interleukin 6 gene polymorphism in healthy subjects.","volume":"2","author":"Ferna\u0301ndez-Real","year":"2001","journal-title":"BMC Med Genet"},{"key":"2019041122173626900_R243","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2337\/diabetes.51.4.1088","article-title":"Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study.","volume":"51","author":"van Exel","year":"2002","journal-title":"Diabetes"},{"key":"2019041122173626900_R244","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0140-6736(92)93288-X","article-title":"Apolipoprotein \u03b54 homozygosity in young men with coronary disease.","volume":"340","author":"Van Bockxmeer","year":"1992","journal-title":"Lancet"},{"key":"2019041122173626900_R245","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/eurheartj\/16.suppl_A.16","article-title":"Genetic regulation of fibrinogen.","volume":"16","author":"Humpries","year":"1995","journal-title":"Eur Heart J"},{"key":"2019041122173626900_R246","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/359641a0","article-title":"Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.","volume":"359","author":"Cambien","year":"1992","journal-title":"Nature"},{"key":"2019041122173626900_R247","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/0002-9149(88)91207-6","article-title":"Relation between family history of coronary artery disease and coronary risk variables.","volume":"62","author":"Jorde","year":"1988","journal-title":"Am J Cardiol"},{"issue":"Suppl 1","key":"2019041122173626900_R248","first-page":"78","article-title":"Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity","volume":"32","author":"Juhan-Vague","year":"2000","journal-title":"Ann Med"},{"key":"2019041122173626900_R249","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.RES.86.12.1259","article-title":"Interleukin-1\u03b2 and tumor necrosis factor-\u03b1 decrease collagen synthesis and increase matrix metalloproteinase activity in vitro.","volume":"86","author":"Siwik","year":"2000","journal-title":"Circ Res"},{"key":"2019041122173626900_R250","first-page":"1241","article-title":"Detection and localization of TNF in human atheroma.","volume":"21","author":"Barath","year":"1989","journal-title":"Am J Cardiol"},{"key":"2019041122173626900_R251","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1161\/01.CIR.94.11.2787","article-title":"Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-\u03b1.","volume":"94","author":"Kaartinen","year":"1996","journal-title":"Circulation"},{"key":"2019041122173626900_R252","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/01.CIR.99.7.861","article-title":"Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease.","volume":"99","author":"Francis","year":"1999","journal-title":"Circulation"},{"key":"2019041122173626900_R253","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0049-3848(00)00315-7","article-title":"Gene polymorphisms in the TNF locus and the risk of myocardial infarction.","volume":"100","author":"Padovani","year":"2000","journal-title":"Thromb Res"},{"key":"2019041122173626900_R254","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/cs0980435","article-title":"Tumour necrosis factor \u03b1 G\u2212308\u2192 A polymorphism and risk for coronary artery disease.","volume":"98","author":"Wang","year":"2000","journal-title":"Clin Sci (Lond)"},{"key":"2019041122173626900_R255","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0021-9150(00)00602-X","article-title":"Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men.","volume":"154","author":"Keso","year":"2001","journal-title":"Atherosclerosis"},{"key":"2019041122173626900_R256","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0021-9150(01)00467-1","article-title":"Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction.","volume":"159","author":"Koch","year":"2001","journal-title":"Atherosclerosis"},{"key":"2019041122173626900_R257","author":"Vendrell"},{"key":"2019041122173626900_R258","author":"Arner","year":"2000"},{"key":"2019041122173626900_R259","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00463-3","article-title":"Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?","volume":"148","author":"Yudkin","year":"2000","journal-title":"Atherosclerosis"},{"key":"2019041122173626900_R260","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1053\/euhj.1999.2207","article-title":"Genetics of inflammation and risk of coronary artery disease: the central role of interleukin 6.","volume":"21","author":"Woods","year":"2000","journal-title":"Eur Heart J"},{"key":"2019041122173626900_R261","first-page":"293","article-title":"Comparative analysis of cytokine induction in human vascular endothelial and smooth muscle cells.","volume":"8","author":"Loppnow","year":"1989","journal-title":"Lymphokine Res"},{"key":"2019041122173626900_R262","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/1043-4666(94)90013-2","article-title":"Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions.","volume":"6","author":"Seino","year":"1994","journal-title":"Cytokine"},{"key":"2019041122173626900_R263","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","article-title":"Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.","volume":"106","author":"Harris","year":"1999","journal-title":"Am J Med"},{"key":"2019041122173626900_R264","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"2019041122173626900_R265","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.CIR.98.8.731","article-title":"Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"2019041122173626900_R266","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/oxfordjournals.aje.a008963","article-title":"Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study.","volume":"144","author":"Kuller","year":"1996","journal-title":"Am J Epidemiol"},{"key":"2019041122173626900_R267","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1161\/01.ATV.0000029781.31325.66","article-title":"Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women.","volume":"22","author":"Bermudez","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041122173626900_R268","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1001\/jama.286.17.2107","article-title":"Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease. Effects of an early invasive or noninvasive strategy.","volume":"286","author":"Lindmark","year":"2001","journal-title":"JAMA"},{"key":"2019041122173626900_R269","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/jc.2002-020092","article-title":"Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women.","volume":"88","author":"Ferrari","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R270","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/01.STR.0000053849.09308.B2","article-title":"Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis: the Carotid Atherosclerosis Progression Study (CAPS).","volume":"34","author":"Jerrard-Dunne","year":"2003","journal-title":"Stroke"},{"key":"2019041122173626900_R271","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/ejvs.2002.1711","article-title":"The \u2212174 G\/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease.","volume":"24","author":"Flex","year":"2002","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2019041122173626900_R272","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00109-002-0354-2","article-title":"The interleukin-6 G(\u2212174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction.","volume":"80","author":"Nauck","year":"2002","journal-title":"J Mol Med"},{"key":"2019041122173626900_R273","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJMoa012673","article-title":"Toll-like receptor 4 polymorphisms and atherogenesis.","volume":"347","author":"Kiechl","year":"2002","journal-title":"N Engl J Med"},{"key":"2019041122173626900_R274","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2337\/diabetes.51.2.455","article-title":"High blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes.","volume":"51","author":"Vozarova","year":"2002","journal-title":"Diabetes"},{"key":"2019041122173626900_R275","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archinte.163.1.93","article-title":"C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984\u20131998.","volume":"163","author":"Thorand","year":"2003","journal-title":"Arch Intern Med"},{"key":"2019041122173626900_R276","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/diacare.25.11.2016","article-title":"Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.","volume":"25","author":"Han","year":"2002","journal-title":"Diabetes Care"},{"key":"2019041122173626900_R277","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1046\/j.1464-5491.2002.00824.x","article-title":"C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study.","volume":"19","author":"Festa","year":"2002","journal-title":"Diabet Med"},{"key":"2019041122173626900_R278","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2337\/diabetes.52.2.442","article-title":"Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study.","volume":"52","author":"Engstrom","year":"2003","journal-title":"Diabetes"},{"key":"2019041122173626900_R279","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/bmj.317.7160.727","article-title":"Relation between iron stores and non-insulin-dependent diabetes in men: case-control study.","volume":"317","author":"Salonen","year":"1998","journal-title":"Br Med J"},{"key":"2019041122173626900_R280","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.2337\/diabetes.51.8.2348","article-title":"Cross-talk between iron metabolism and diabetes.","volume":"51","author":"Ferna\u0301ndez-Real","year":"2002","journal-title":"Diabetes"},{"key":"2019041122173626900_R281","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1046\/j.1523-1755.2000.00331.x","article-title":"Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.","volume":"58","author":"Festa","year":"2000","journal-title":"Kidney Int"},{"key":"2019041122173626900_R282","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2337\/diabetes.51.4.1157","article-title":"Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.","volume":"51","author":"Stehouwer","year":"2002","journal-title":"Diabetes"},{"key":"2019041122173626900_R283","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0198-8859(95)00177-8","article-title":"An association in non-insulin-dependent diabetes mellitus subjects between susceptibility to retinopathy and tumor necrosis factor polymorphism.","volume":"46","author":"Hawrami","year":"1996","journal-title":"Hum Immunol"},{"key":"2019041122173626900_R284","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000050877","article-title":"Duration of non-insulin-dependent diabetes mellitus and the TNF-\u03b2 NcoI genotype as predictive factors in proliferative diabetic retinopathy.","volume":"215","author":"Kankova","year":"2001","journal-title":"Ophthalmologica"},{"key":"2019041122173626900_R285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0168-8227(01)00269-8","article-title":"Tumor necrosis factor allelic polymorphism with diabetic retinopathy in India.","volume":"54","author":"Kumaramanickavel","year":"2001","journal-title":"Diabetes Res Clin Pract"},{"key":"2019041122173626900_R286","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s00125-001-0766-5","article-title":"The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm.","volume":"45","author":"Dandona","year":"2002","journal-title":"Diabetologia"},{"key":"2019041122173626900_R287","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0899-9007(01)00518-4","article-title":"Is insulin an antiinflammatory molecule?","volume":"17","author":"Das","year":"2001","journal-title":"Nutrition"},{"key":"2019041122173626900_R288","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0735-1097(95)00126-K","article-title":"Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.","volume":"26","author":"Malmberg","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"2019041122173626900_R289","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in the critically ill patients.","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"2019041122173626900_R290","first-page":"1306","article-title":"Suppression of nuclear factor-\u03baB and stimulation of inhibitor \u03baB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese.","volume":"86","author":"Ghanim","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R291","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.0000025403.20953.23","article-title":"Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.","volume":"106","author":"Haffner","year":"2002","journal-title":"Circulation"},{"key":"2019041122173626900_R292","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/01.HYP.0000036396.64769.C2","article-title":"Antiinflammatory and antiarteriosclerotic effects of pioglitazone.","volume":"40","author":"Ishibashi","year":"2002","journal-title":"Hypertension"},{"key":"2019041122173626900_R293","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122173626900_R294","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R295","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/diabetes.50.5.1126","article-title":"Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.","volume":"50","author":"Hotta","year":"2001","journal-title":"Diabetes"},{"key":"2019041122173626900_R296","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1210\/jcem.86.8.7741","article-title":"Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.","volume":"86","author":"Yang","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R297","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"2019041122173626900_R298","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","article-title":"Prevention of fat-induced insulin resistance by salicylate.","volume":"108","author":"Kim","year":"2001","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R299","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","article-title":"Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikk\u03b2.","volume":"293","author":"Yuan","year":"2001","journal-title":"Science"},{"key":"2019041122173626900_R300","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI0214955","article-title":"Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes.","volume":"109","author":"Hundal","year":"2002","journal-title":"J Clin Invest"},{"key":"2019041122173626900_R301","first-page":"1894","article-title":"Genetic variability in insulin action inhibitor Ikk\u03b2 (IKBKB) does not play a major role in the development of type 2 diabetes.","volume":"87","author":"Menzaghi","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R302","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.103.3.357","article-title":"Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.","volume":"103","author":"Freeman","year":"2001","journal-title":"Circulation"},{"key":"2019041122173626900_R303","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(98)05917-0","article-title":"Inhibition of proinflammatory cytokine production by pravastatin.","volume":"353","author":"Rosenson","year":"1999","journal-title":"Lancet"},{"key":"2019041122173626900_R304","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"2019041122173626900_R305","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"2019041122173626900_R306","first-page":"R1327","article-title":"Cytokine-induced glucose uptake in skeletal muscle:redox regulation and the role of \u03b1-lipoic acid","volume":"276","author":"Khanna","year":"1999","journal-title":"Am J Physiol"},{"key":"2019041122173626900_R307","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0891-5849(99)00089-1","article-title":"Oral administration of RAC-\u03b1-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial.","volume":"27","author":"Jacob","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"2019041122173626900_R308","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2273.1995.tb00034.x","article-title":"The effect of recurrent tonsillitis and tonsillectomy on growth in childhood.","volume":"20","author":"Camilleri","year":"1995","journal-title":"Clin Otolaryngol"},{"key":"2019041122173626900_R309","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0960-9822(98)70133-2","article-title":"The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor.","volume":"8","author":"Shapiro","year":"1998","journal-title":"Curr Biol"},{"key":"2019041122173626900_R310","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1210\/jc.2002-020173","article-title":"CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity.","volume":"88","author":"Ferna\u0301ndez-Real","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122173626900_R311","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0952-7915(97)80152-5","article-title":"1995 Innate immunity: impact on the adaptive immune response.","volume":"9","author":"Medzhitov","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"2019041122173626900_R312","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0952-7915(95)80029-8","article-title":"Structure and function of the pentraxins.","volume":"7","author":"Gewurz","year":"1995","journal-title":"Curr Opin Immunol"},{"key":"2019041122173626900_R313","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1001\/jama.286.17.2136","article-title":"Association between myeloperoxidase levels and risk of coronary artery disease.","volume":"286","author":"Zhang","year":"2001","journal-title":"JAMA"},{"key":"2019041122173626900_R314","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1126\/science.1106830","article-title":"Myeloperoxidase, a leukocyte-derived vascular NO oxidase.","volume":"296","author":"Eiserich","year":"2002","journal-title":"Science"},{"key":"2019041122173626900_R315","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/hc0102.101362","article-title":"Impact of infectious burden on extent and long-term prognosis of atherosclerosis.","volume":"105","author":"Espinola-Klein","year":"2002","journal-title":"Circulation"},{"key":"2019041122173626900_R316","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(96)06413-6","article-title":"Genetic influence on cytokine production and fatal meningococcal disease.","volume":"349","author":"Westendorp","year":"1997","journal-title":"Lancet"},{"key":"2019041122173626900_R317","doi-asserted-by":"crossref","first-page":"E326","DOI":"10.1152\/ajpendo.2001.281.2.E326","article-title":"Prenatal cytokine exposure results in obesity and gender-specific programming","volume":"281","author":"Dahlgren","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041122173626900_R318","first-page":"1","article-title":"Thrifty genotype: how applicable is it to obesity and type 2 diabetes?","volume":"7","author":"Lev-Ran","year":"1999","journal-title":"Diabetes Rev"},{"key":"2019041122173626900_R319","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/19431","article-title":"Defense by diversity.","volume":"398","author":"Hill","year":"1999","journal-title":"Nature"},{"key":"2019041122173626900_R320","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/35036627","article-title":"The large-scale organization of metabolic networks.","volume":"407","author":"Jeong","year":"2000","journal-title":"Nature"},{"key":"2019041122173626900_R321","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2337\/diacare.22.1.45","article-title":"Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.","volume":"22","author":"Bjornholt","year":"1999","journal-title":"Diabetes Care"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/24\/3\/278\/8860763\/edrv0278.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T10:30:39Z","timestamp":1682505039000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/24\/3\/278\/2424224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,1]]},"references-count":321,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,11,7]]},"published-print":{"date-parts":[[2003,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2002-0010","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,1]]}}}